Skip to Main Content

Author Details

Chyung-Ru Wang
Feinberg School of Medicine, Northwestern University
1987
103
44
PMIDPaper TitleJournal TitlePublished Year
36945395Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells.bioRxiv2023
37877801Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells.Elife2023
34176438Structure and dynamics of major histocompatibility class Ib molecule H2-M3 complexed with mitochondrial-derived peptides.J Biomol Struct Dyn2022
35926466METTL14-dependent m<sup>6</sup>A modification controls iNKT cell development and function.Cell Rep2022
34130802CD1-Restricted T Cells in Inflammatory Skin Diseases.J Invest Dermatol2022
33753493Mitochondrial metabolism is essential for invariant natural killer T cell development and function.Proc Natl Acad Sci U S A2021
35381140Role of Group 1 CD1-Restricted T Cells in Host Defense and Inflammatory Diseases.Crit Rev Immunol2021
32343740Group 1 CD1-restricted T cells contribute to control of systemic Staphylococcus aureus infection.PLoS Pathog2020
32069354USP22 controls iNKT immunity through MED1 suppression of histone H2A monoubiquitination.J Exp Med2020
33312179Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant <i>Staphylococcus aureus</i> Infection.Front Immunol2020
31540125Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice.Int J Mol Sci2019
29358051Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair.Cell2018
30061888Linking CD1-Restricted T Cells With Autoimmunity and Dyslipidemia: Lipid Levels Matter.Front Immunol2018
30538700Induction of <i>Mycobacterium Tuberculosis</i> Lipid-Specific T Cell Responses by Pulmonary Delivery of Mycolic Acid-Loaded Polymeric Micellar Nanocarriers.Front Immunol2018
28723564The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation.Cell Rep2017
28463230CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice.J Clin Invest2017
28475642MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.PLoS Pathog2017
28596110Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.J Hepatol2017
27272249Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection.PLoS Pathog2016
27757307CD1b-autoreactive T cells recognize phospholipid antigens and contribute to antitumor immunity against a CD1b<sup>+</sup> T cell lymphoma.Oncoimmunology2016
26175733Role of Group 1 CD1-Restricted T Cells in Infectious Disease.Front Immunol2015
26652001Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model.Elife2015
26519537Pak2 Controls Acquisition of NKT Cell Fate by Regulating Expression of the Transcription Factors PLZF and Egr2.J Immunol2015
24550295Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.Proc Natl Acad Sci U S A2014
25236978The adaptor protein SAP regulates type II NKT-cell development, cytokine production, and cytotoxicity against lymphoma.Eur J Immunol2014
25057452Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides.Oncoimmunology2014
23518808The functions of type I and type II natural killer T cells in inflammatory bowel diseases.Inflamm Bowel Dis2013
23415911Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.Immunity2013
22057113dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice.Gastroenterology2012
23041566SAP is required for the development of innate phenotype in H2-M3--restricted Cd8(+) T cells.J Immunol2012
23142773Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.Nat Immunol2012
21098224Nonconventional CD8+ T cell responses to Listeria infection in mice lacking MHC class Ia and H2-M3.J Immunol2011
21860021Autoreactive CD1b-restricted T cells: a new innate-like T-cell population that contributes to immunity against infection.Blood2011
21788511Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells.Proc Natl Acad Sci U S A2011
21695190CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.PLoS One2011
21148815Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells.Blood2011
20642679Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.Am J Transplant2010
20927351CD1d expression in paneth cells and rat exocrine pancreas revealed by novel monoclonal antibodies which differentially affect NKT cell activation.PLoS One2010
19179286Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.Proc Natl Acad Sci U S A2009
19808251CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.J Exp Med2009
19424015Antagonistic effect of toll-like receptor signaling and bacterial infections on transplantation tolerance.Transplantation2009
18424719Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes.J Immunol2008
18772281Bacterial infection alters the kinetics and function of iNKT cell responses.J Leukoc Biol2008
18541714An MHC class Ib-restricted CD8 T cell response confers antiviral immunity.J Exp Med2008
18628995Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.PLoS One2008
17322392Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis.Am J Pathol2007
16557300Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis.J Clin Invest2006
17096643Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation.Parasite Immunol2006
17114455IFN-beta-mediated up-regulation of CD1d in bacteria-infected APCs.J Immunol2006
17082618Activating transcription factor/cAMP response element binding protein family member regulated transcription of CD1A.J Immunol2006
  • 1 - 50 of 103

Recommended Authors

Novo Nordisk Research Center Seattle, Inc.
Career Start Year 2003
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Center for Infectious Medicine, Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
University of California San Diego
Career Start Year 1999
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1998
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 11
University of Perugia
Career Start Year 1995
Number of shared co-authors 1
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 0
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Universidad Cardenal Herrera-CEU, CEU Universities
Career Start Year 1989
Number of shared co-authors 0
University of Perugia
Career Start Year 1988
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1986
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1986
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 0
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 1
University of Massachusetts School of Medicine
Career Start Year 1976
Number of shared co-authors 0
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 1976
Number of shared co-authors 0
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
A. Menarini Biomarkers Singapore Pte Ltd
Career Start Year 1973
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 12
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 5
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 1

Collaborators

Co-authored papers 4
National Jewish Health
Co-authored papers 2
University of Ghana
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
University of Miami Miller School of Medicine
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Louisiana State University
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Cedars-Sinai Medical Center, USA F. Widjaja Inflammatory Bowel Disease Institute
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Genentech Inc.
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
National Institute of Arthritis, National Institutes of Health
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Beth Israel Deaconess Medical Center and Harvard Medical School
Co-authored papers 1
Co-authored papers 1
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Co-authored papers 1
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Co-authored papers 1
University Hospital Southampton
Co-authored papers 1